Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- história familiar de convulsões na infância
- episódio de olhar fixo, que dura de 5 a 10 segundos; várias vezes por dia sem aura/estado pós-ictal
- início na infância
- exame físico normal
- crise induzida por hiperventilação
Otros factores de diagnóstico
- Automatismos
- declínio recente no desempenho escolar
- início precoce (antes dos 4 anos)
Factores de riesgo
- história familiar/genética de síndrome epiléptica do tipo ausência
- lesão cerebral adquirida: por exemplo, hipóxia-isquemia, trauma, infecção
- outros defeitos congênitos do metabolismo, defeitos estruturais, anormalidades cromossômicas
- atraso no desenvolvimento ou deficiência intelectual
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- eletroencefalograma (EEG)
Pruebas diagnósticas que deben considerarse
- ressonância nuclear magnética (RNM) cranioencefálica
- exames para distúrbios metabólicos (por exemplo, aminoácidos séricos, ácidos orgânicos urinários, piruvato de lactato ou testes enzimáticos específicos)
- glicose no líquido cefalorraquidiano e glicose sérica
- teste genético
Algoritmo de tratamiento
crises de ausência típica sem história de crises tônico-clônicas generalizadas (epilepsia do tipo ausência da infância)
crises de ausência típica com história de crises tônico-clônicas generalizadas (epilepsia do tipo ausência da infância [EAI], epilepsia do tipo ausência juvenil [EAJ] e epilepsia mioclônica juvenil [EMJ])
crises de ausência atípica
refratário a tratamento
Colaboradores
Autores
Emily McGinnis, MD
Clinical Assistant Professor
Department of Clinical Science
Kaiser Permanente Bernard J. Tyson School of Medicine
Los Angeles
CA
Divulgaciones
EM states that she has no competing interests.
Dean Sarco, MD
Clinical Associate Professor
Department of Clinical Science
Kaiser Permanente Bernard J. Tyson School of Medicine
Los Angeles
CA
Divulgaciones
DS states that he has no competing interests.
Agradecimientos
Dr Emily McGinnis and Dr Dean Sarco would like to gratefully acknowledge Dr Michael Wong and Dr Judith L. Z. Weisenberg, previous contributors to this topic.
Divulgaciones
MW and JLZW declare that they have no competing interests.
Revisores por pares
Anita Devlin, MBBS, MD
Consultant Paediatric Neurologist
Royal Victoria Infirmary
NHS Foundation Trust
Newcastle-upon-Tyne
UK
Divulgaciones
AD and two epilepsy nurses from her department have been reimbursed by UCB Pharma, the manufacturer of levetiracetam, for attending several conferences. One of the epilepsy nurses received a one-off sponsorship payment from UCB Pharma to cover the initial set-up costs of the adolescent epilepsy support group. One epilepsy nurse has been reimbursed by Cyberonics, the manufacturer of vagal nerve stimulators, for attending one or more conferences.
Cigdem Akman, MD
Division of Pediatric Neurology
Columbia University College of Physicians and Surgeons
New York
NY
Divulgaciones
CA declares that he has no competing interests.
Angus A. Wilfong, MD
Associate Professor
Pediatrics and Neurology
Baylor College of Medicine
Medical Director
Comprehensive Epilepsy Program
Texas Children's Hospital
Houston
TX
Divulgaciones
AAW declares that he has no competing interests.
Helen Cross, MB, ChB, PhD, FRCP, FRCPCH
Head of Neurosciences Unit
The Prince of Wales’s Chair of Childhood Epilepsy
National Centre for Young People with Epilepsy
London
UK
Divulgaciones
HC has received research funds from HAS, Epilepsy Research UK, SHS, and the Milk Development Council. She has received funding for an epilepsy training fellowship from UCB and Eisai. She has also received travel funding from Eisai, UCB, and GlaxoSmithKline.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Beniczky S, Trinka E, Wirrell E, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025 Jun;66(6):1804-23.Texto completo Resumen
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017 Apr;58(4):512-21.Texto completo Resumen
Hirsch E, French J, Scheffer IE, et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1475-99.Texto completo Resumen
Specchio N, Wirrell EC, Scheffer IE, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1398-442.Texto completo Resumen
Brigo F, Igwe SC, Lattanzi S. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2021 Jan 21;1(1):CD003032.Texto completo Resumen
Rinaldi VE, Di Cara G, Mencaroni E, et al. Therapeutic options for childhood absence epilepsy. Pediatr Rep. 2021 Dec 16;13(4):658-67.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Sonhar acordado
- Transtorno de deficit da atenção com hiperatividade (TDAH)
- Crises focais com comprometimento da consciência, de origem no lobo frontal ou temporal
Más DiferencialesGuías de práctica clínica
- Epilepsies in children, young people and adults
- Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication
Más Guías de práctica clínicaFolletos para el paciente
Crises de ausência em crianças
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad